FDA approves Tibotec's TMC114 for HIV

FDA approved Prezista darunavir (formerly TMC114) from Tibotec (Cork, Ireland) for use in combination with a low-dose of ritonavir and other anti-HIV agents to treat HIV infection in patients who have...